The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 0
  • Not found in our database.
parent relation
Company in focus

SUMITOMO DAINIPPON PHARMA CO., LTD.


  • SUMITOMO DAINIPPON PHARMA CO., LTD.
    S
    Registered number 1200-01-077477
    6-8, Doshomachi 2-chome, Chuo-ku, Osaka, 541-0045, Japan
    Corporate in Osaka Legal Affairs Bureau, Japan
    CIF 1
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
Ceased 1
  • SUNOVION PHARMACEUTICALS EUROPE LTD. - 2021-08-23
    SUNOVION PHARMACEUTICALS EUROPE. LTD - 2013-10-09
    SUNOVION PHARMACEUTICALS EUROPE LTD - 2013-04-02
    DAINIPPON SUMITOMO PHARMA EUROPE LTD. - 2013-04-02
    SUMITOMO PHARMACEUTICALS EUROPE LIMITED - 2006-04-03
    SUMITOMO PHARMACEUTICALS UK LIMITED - 2001-10-01
    3 Bunhill Row, London, England
    Active Corporate (3 parents, 1 offspring)
    Person with significant control
    2016-04-06 ~ 2021-08-17
    CIF 1 - Ownership of shares – 75% or more OE
    CIF 1 - Ownership of voting rights - 75% or more OE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.